MedTrace Logo

Dysport® Adult Upper Limb Spasticity

NCT01313299 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 243

Last updated 2022-09-28

Study results available
· View outcomes & findings →

Summary

The purpose of this research study is to assess the efficacy of Dysport compared to placebo in improving muscle tone in hemiparetic subjects with upper limb spasticity due to stroke or traumatic brain injury.

Conditions

  • Nervous System Disorders

Interventions

BIOLOGICAL

Botulinum toxin type A

500 U, I.M. (in the muscle) injection on day 1 of a single treatment cycle.

BIOLOGICAL

Botulinum toxin type A

1000 U, I.M. (in the muscle) injection on day 1 of a single treatment cycle.

DRUG

Placebo

I.M. (in the muscle) injection on day 1 of a single treatment cycle.

Sponsors & Collaborators

Principal Investigators

  • Ipsen Study Director · Ipsen

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-08-31
Primary Completion
2013-09-30
Completion
2013-09-30

Countries

  • United States
  • Belgium
  • Czechia
  • France
  • Hungary
  • Italy
  • Poland
  • Russia
  • Slovakia

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01313299 on ClinicalTrials.gov